Proportion of Patients Followed in a Specialized Heart Failure Clinic Needing an Implantable Cardioverter Defibrillator as Determined by Applying Different Trial Eligibility Criteria
- 1 March 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (6) , 882-885
- https://doi.org/10.1016/j.amjcard.2005.09.138
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sudden Death after Myocardial Infarction — Who Needs Prophylaxis, and When?New England Journal of Medicine, 2005
- Not Everyone With an Ejection Fraction ≤30% Should Receive an ICDCirculation, 2005
- Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-IIAnnals of Internal Medicine, 2005
- Preventing Sudden Cardiac Death: Can We Afford the Benefit?Annals of Internal Medicine, 2005
- Medicare Coverage of ICDsNew England Journal of Medicine, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated CardiomyopathyNew England Journal of Medicine, 2004
- Implantable Cardioverter Defibrillators in Primary and Secondary PreventionAnnals of Internal Medicine, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Expensive medical technologies and “indication extrapolation”: The case of implantable cardioverter-defibrillatorsAmerican Heart Journal, 2000